IL6R and coronary atherosclerosis: On the basis of genetic evidence, IL6R-related pro-inflammatory pathway seems to have a causal role in the pathogenesis of coronary atherosclerosis, and IL6R blockade could be a novel therapeutic approach for prevention of coronary atherosclerotic disease (Boekholdt and Stroes, 2012).